Dr Alcamí is an expert in HIV pathogenesis, in particular in the mechanisms involved in HIV latency, immune mechanisms of virus control and viral entry. Besides, his group has developed new strategies to tackle HIV infection in the field of anti-latency drugs, microbicides and has developed new prototypes of preventive HIV vaccines. Currently he is Research Professor and leads the AIDS Immunopathogenesis Unit at Instituto de Salud Carlos III, one of the most important basic research groups in the HIV field in Spain. With 15 researchers, the IP-LAB addresses different aspects of HIV pathogenesis, drug discovery and vaccine development.